Funding for breast cancer detection
Article Date: Jul 14 2008Dexela, a company developing 3D imaging technology focused on the early detection of breast cancer, has raised equity finance of £2.6 million. The main investors in the funding round are venture capital investors Close Ventures and the London Technology Fund.
The money will be used to support the ongoing development and commercialisation of the technology owned by Dexela, which has raised £4.7 million to date via two funding rounds and business grants.
Andrew Elder, director of Close Ventures, comments: ‘Dexela’s breast imaging technology has the potential to contribute where there is a major area of unmet diagnostic and medical need.’
Edward Bullard, chief executive of Dexela, says that the company has progressed considerably over the past year, adding, ‘[we believe] that this technology will contribute significantly to the improvement of breast cancer screening and diagnosis, including outcomes and cost, around the world.’
The technology aims to reduce the number of false negatives and false positives in conventional mammography.
